Atherosclerosis and Lipids Management Summit [Non-CME]

Program Director(s)

• 

  Hector Garcia-Garcia, MD, PhD

  Director of Invasive Imaging Core Laboratory
  MedStar Washington Hospital Center
  Washington, District of Columbia, United States
• 

  Ron Waksman, MD, MSCAI

  Director, Cardiovascular Research and Advanced Education
  MedStar Washington Hospital Center, MedStar Heart and Vascular Institute
  Washington, District of Columbia, United States

Presentations:

• 2:00 PM – 2:19 PM ET

  Keynote | Why Do We Need New Lipid Lowering Therapies?
  

  Keynote Speaker: Robert S. Rosenson, MD – Mount Sinai Health System
• 2:00 PM – 3:41 PM ET

  INSIGHTS INTO THE PATHOPHYSIOLOGY AND MECHANISMS AND IMAGING OF THE ATHEROSCLEROTIC DISEASE
  

  Moderator: Habib Samady, MD, FACC – Georgia Heart Institute, Northeast Georgia Health System

  Moderator: Angela M. Taylor, MD, MS, MBA – University of Virginia

  Moderator: Renu Virmani, MD – CVPath Institute, Inc.
• 2:19 PM – 2:38 PM ET

  Keynote | Old and New Medical Therapies to Reduce Inflammation
  

  Keynote Speaker: Paul M. Ridker, MD – Brigham and Womens Hospital
• 2:38 PM – 2:46 PM ET

  Biomechanical Indices of Plaque Vulnerability
  

  Speaker: Habib Samady, MD, FACC – Georgia Heart Institute, Northeast Georgia Health System
• 2:46 PM – 2:54 PM ET

  Preclinical Atherosclerosis is Worth Going After
  

  Speaker: Renu Virmani, MD – CVPath Institute, Inc.
• 2:54 PM – 3:02 PM ET

  Vulnerable Plaque 2024 - Where do we Stand from the Pathologic Perspective
  

  Speaker: Aloke V. Finn, MD – CVPath
• 3:02 PM – 3:10 PM ET

  The Role of ApoA-1 on Atherosclerosis Progression in Psoriasis
  

  Speaker: Nehal N. Mehta, MD, MSCE – The George Washington University
• 3:10 PM – 3:18 PM ET

  Vulnerable Plaque "Features": Which One Should We Look For?
  

  Speaker: Francesco Prati, MD – San Giovanni Hospital Rome, Italy
• 3:18 PM – 3:26 PM ET

  PROSPECT II Sub-Studies
  

  Speaker: David Erlinge, MD, PhD – Lund University
• 3:26 PM – 3:41 PM ET

  Panel Discussion: Our Understanding on the Pathophysiology and Mechanism of Atherosclerosis and the VP
  

  Panel Moderator: Habib Samady, MD, FACC – Georgia Heart Institute, Northeast Georgia Health System

  Panel Moderator: Angela M. Taylor, MD, MS, MBA – University of Virginia

  Panel Moderator: Renu Virmani, MD – CVPath Institute, Inc.

  Panel Discussant: H. Bryan Brewer, Jr., MD – MedStar Cardiovascular Research Network

  Panel Discussant: David Erlinge, MD, PhD – Lund University

  Panel Discussant: Zorina S. Galis, PhD – National Institutes of Health

  Panel Discussant: Natalia Pinilla, MD, PhD – McMaster University

  Panel Discussant: Francesco Prati, MD – San Giovanni Hospital Rome, Italy

  Panel Discussant: Paul M. Ridker, MD – Brigham and Womens Hospital

  Panel Discussant: Nehal N. Mehta, MD, MSCE – The George Washington University
• 3:41 PM – 3:49 PM ET

  Update in NIRAF and NIRF Inflammation Imaging
  

  Speaker: Farouc A. Jaffer, MD, PhD – Massachusetts General Hospital / Harvard Medical School
• 3:41 PM – 5:08 PM ET

  ADVANCES IN IMAGING OF THE ATHEROSCLEROTIC PLAQUE
  

  Moderator: Zorina S. Galis, PhD – National Institutes of Health

  Moderator: Hector M. Garcia-Garcia, MD, PhD – MedStar Washington Hospital Center
• 3:49 PM – 3:57 PM ET

  Multifocal Unstable and Vulnerable Plaques: Detection and Management
  

  Speaker: James A. Goldstein, MD, FSCAI – Beaumont Health System
• 3:57 PM – 4:05 PM ET

  Update of Molecular NIRF-IVUS Imaging
  

  Speaker: Michael H. Joner, MD – Deutsches Herzzentrum Muenchen
• 4:05 PM – 4:13 PM ET

  Application of AI to the Imaging of Vulnerable Plaque in Coronary Arteries
  

  Speaker: Giulio Guagliumi, Sr., MD – IRCCS Galeazzi Sant'Ambrogio Hospital,
• 4:13 PM – 4:21 PM ET

  Resolution of Inflammation and Current Understanding of Plaque Regression
  

  Speaker: Pedro R. Moreno, MD, FACC – Mount Sinai Hospital
• 4:21 PM – 4:29 PM ET

  Noninvasive Plaque Morphology Versus Functional Assessment to Detect Vulnerable Plaque
  

  Speaker: Jonathon Leipsic, MD, FRCPC – St. Paul's Hospital
• 4:29 PM – 4:37 PM ET

  CAD Patterns and Plaque Vulnerability: A Multimodality Imaging and Physiology Approach
  

  Speaker: Farouc A. Jaffer, MD, PhD – Massachusetts General Hospital / Harvard Medical School
• 4:37 PM – 4:45 PM ET

  Clinical Trial Designs for PCI of Vulnerable Plaque
  

  Speaker: Gregg W. Stone, MD, FACC, MSCAI – Mount Sinai
• 4:45 PM – 5:00 PM ET

  Panel Discussion | Advances of Imaging to Detect Vulnerable Plaque: Can We Trust What We See?
  

  Panel Moderator: Zorina S. Galis, PhD – National Institutes of Health

  Panel Moderator: Hector M. Garcia-Garcia, MD, PhD – MedStar Washington Hospital Center

  Panel Discussant: Hiram G. Bezerra, MD, PhD – Tampa General / USF

  Panel Discussant: Farouc A. Jaffer, MD, PhD – Massachusetts General Hospital / Harvard Medical School

  Panel Discussant: Michael H. Joner, MD – Deutsches Herzzentrum Muenchen

  Panel Discussant: Arnav Kumar, MD, MSCR – The University of Houston Tilman J. Fertitta Family College of Medicine HCA Houston Heart Medical Center

  Panel Discussant: Pedro R. Moreno, MD, FACC – Mount Sinai Hospital

  Panel Discussant: Natalia Pinilla, MD, PhD – McMaster University
• 5:00 PM – 5:08 PM ET

  Biological Basis and Proposed Mechanism of Action of CSL112 (apolipoprotein A-I [human]) for Prevention of Major Adverse Cardiovascular Events in Patients with Myocardial Infarction
  

  Speaker: C. Michael Gibson, MD – Beth Israel Deaconess Medical Center
• 5:00 PM – 6:30 PM ET

  ATHEROSCLEROSIS THERAPEUTIC OPTIONS AND MANAGEMENT
  

  Moderator: David Erlinge, MD, PhD – Lund University

  Moderator: Biljana Parapid, MD, PhD – Belgrade University School of Medicine

  Moderator: Allen J. Taylor, MD – MedStar Heart and Vascular Institute

  Moderator: Ron Waksman, MD, MSCAI – MedStar Washington Hospital Center, MedStar Heart and Vascular Institute
• 5:08 PM – 5:16 PM ET

  Lipoprotein(a) - A Multifarious Lipoprotein at the Nexus of Inflammation and Thrombosis
  

  Speaker: Robert S. Rosenson, MD – Mount Sinai Health System
• 5:16 PM – 5:24 PM ET

  State of the Art in LDL-C Assessment & Management: How Low Can We Go?
  

  Speaker: Francoise Marvel, MD – John Hopkins University
• 5:24 PM – 5:32 PM ET

  Emerging Therapies for Lp(a)
  

  Speaker: Scott W. Shurmur, MD – Texas Tech Health Sciences Center, Lubbock
• 5:32 PM – 5:40 PM ET

  Is Targeting Platelets and Coagulation Sufficient to Reduce the Risk of Ischemic Event Associated with Vulnerable Plaque Rupture?
  

  Speaker: Paul A. Gurbel, MD, FSCAI – Sinai Center for Thrombosis Research and Drug Development
• 5:40 PM – 5:48 PM ET

  Targeting Inflammation in Atherosclerosis
  

  Speaker: Paul M. Ridker, MD – Brigham and Womens Hospital
• 5:48 PM – 5:56 PM ET

  Inflammatory HDL
  

  Speaker: Allen J. Taylor, MD – MedStar Heart and Vascular Institute
• 5:56 PM – 6:04 PM ET

  Vulnerable Plaques Can Be Detected: What Are the Implications for Research and Clinical Practice?
  

  Speaker: James E. Muller, MD – Brigham and Women's Hospital
• 6:04 PM – 6:12 PM ET

  What Will Be New in Lipid Lowering Therapies? Rethinking Old Paradigms
  

  Speaker: Robert S. Rosenson, MD – Mount Sinai Health System
• 6:12 PM – 6:30 PM ET

  Panel Discussion: Atherosclerosis Therapeutic Options and Management
  

  Panel Moderator: David Erlinge, MD, PhD – Lund University

  Panel Moderator: Biljana Parapid, MD, PhD – Belgrade University School of Medicine

  Panel Moderator: Allen J. Taylor, MD – MedStar Heart and Vascular Institute

  Panel Moderator: Ron Waksman, MD, MSCAI – MedStar Washington Hospital Center, MedStar Heart and Vascular Institute

  Panel Discussant: H. Bryan Brewer, Jr., MD – MedStar Cardiovascular Research Network

  Panel Discussant: Paul A. Gurbel, MD, FSCAI – Sinai Center for Thrombosis Research and Drug Development

  Panel Discussant: Francoise Marvel, MD – John Hopkins University

  Panel Discussant: Gregg W. Stone, MD, FACC, MSCAI – Mount Sinai

  Panel Discussant: Deepak Talreja, MD – Sentara

  Panel Discussant: Ori Waksman, MD
• 6:30 PM ET

  Adjourn